These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37182156)

  • 41. Development and Validation of a Practical Prognostic Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
    Wang Q; Cao B; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Han Y; Lang J; Mi K
    Ann Surg Oncol; 2021 Dec; 28(13):8450-8461. PubMed ID: 34101065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer.
    Deng Q; Long Q; Liu Y; Yang Z; Du Y; Chen X
    BMC Cancer; 2021 Nov; 21(1):1282. PubMed ID: 34844568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mean platelet volume as a potential biomarker for survival outcomes in ovarian clear cell carcinoma.
    Yoshikawa N; Matsukawa T; Hattori S; Iyoshi S; Yoshida K; Yoshihara M; Tamauchi S; Shimizu Y; Ikeda Y; Yokoi A; Niimi K; Kawai M; Kajiyama H
    Int J Clin Oncol; 2023 Dec; 28(12):1680-1689. PubMed ID: 37804356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
    Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
    Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.
    Wang L; Wang C; Wang J; Huang X; Cheng Y
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):2077-2086. PubMed ID: 28601935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
    Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
    Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lack of any prognostic value of body mass index for patients undergoing chemoradiotherapy for esophageal squamous cell carcinoma.
    Zhang F; Wang CS; Sun B; Tian GB; Cao FL; Cheng YF
    Asian Pac J Cancer Prev; 2014; 15(7):3075-9. PubMed ID: 24815450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study.
    Xie C; Chen Z; Xu J; Meng Z; Huang Z; Lin J
    PeerJ; 2022; 10():e12974. PubMed ID: 35256918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
    Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
    Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of platelet-related measures for overall survival in esophageal squamous cell carcinoma: A systematic review and meta-analysis.
    Ishibashi Y; Tsujimoto H; Sugasawa H; Kouzu K; Itazaki Y; Sugihara T; Harada M; Ito N; Kishi Y; Ueno H
    Crit Rev Oncol Hematol; 2021 Aug; 164():103427. PubMed ID: 34273499
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis.
    Yamamoto M; Shimokawa M; Yoshida D; Yamaguchi S; Ohta M; Egashira A; Ikebe M; Morita M; Toh Y
    J Cancer Res Clin Oncol; 2020 May; 146(5):1351-1360. PubMed ID: 32185488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
    Kaida H; Yasuda T; Shiraishi O; Kato H; Kimura Y; Hanaoka K; Yamada M; Matsukubo Y; Tsurusaki M; Kitajima K; Hattori S; Ishii K
    BMC Cancer; 2022 Nov; 22(1):1176. PubMed ID: 36376801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
    Tu CC; Hsu PK; Chien LI; Liu WC; Huang CS; Hsieh CC; Hsu HS; Wu YC
    BMC Cancer; 2017 Jan; 17(1):62. PubMed ID: 28103913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The flow-metabolism ratio might predict treatment response and survival in patients with locally advanced esophageal squamous cell carcinoma.
    Zhao K; Wang C; Mao Q; Shang D; Huang Y; Ma L; Yu J; Li M
    EJNMMI Res; 2020 May; 10(1):57. PubMed ID: 32472227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative mean platelet volume is a prognostic biomarker for survival in patients with gastric cancer: A cohort study.
    An S; Eo W; Han GY; Park S; Lee S
    Medicine (Baltimore); 2022 Sep; 101(36):e30504. PubMed ID: 36086726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy.
    Huang TC; Liang CW; Li YI; Guo JC; Lin CC; Chen YJ; Cheng AL; Hsu CH
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1803-1811. PubMed ID: 34432128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low preoperative albumin-globulin score predicts favorable survival in esophageal squamous cell carcinoma.
    Zhang F; Sun P; Wang ZQ; Wang de S; Wang Y; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
    Oncotarget; 2016 May; 7(21):30550-60. PubMed ID: 27105522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.